Pulsed Field Ablation of Atrial Fibrillation: CENTAURI Versus FARAPULSE

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 325 participants.

Also called NCT07902739

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 325 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT07902739
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Czechia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT07902739. Randomized; no masking; primary purpose treatment. Start 2024-05-17 (actual); primary completion 2026-10-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pulsed Field Ablation of Atrial Fibrillation: CENTAURI Versus FARAPULSE
Condition
Atrial Fibrillation (AF)
Condition
Paroxysmal AF
Condition
Persistent AF
Intervention (Device)
CENTAURI PEF system
Intervention (Device)
FARAPULSE system
Lead sponsor
St. Anne's University Hospital Brno, Czech Republic (class: other)

Record details

Record id
cardio:ct-nct07902739
Content hash
f9926b3639ca9e38fe72a8995e3bf3c13a7595fb7af04a06e85fac88644891e7